Radical prostatectomy (RPE) and
brachytherapy (BT) belong to main
options of prostate cancer (CaP)
treatment. Up to present time there
are no researches dedicated to comparative
analysis of these methods.
Discovering the advantages of one
of these methods may help to provide
their efficiency analysis. In
terms of retrospective assessment
of retropubic radical prostatectomy
and brachytherapy using I-125 in
300 patients with prostate cancer
clinic-economic analysis was performed.
Data on main expenses
for these treatment options was received.
Possible costs of these methods
for government were assessed.
Radical prostatectomy was considered
more cost-effective. According
to research data expenses for one recurrence
free life year of patient after
radical prostatectomy amounted
41'668.82 rubles, after brachytherapy– 153'188.36 rubles. The cost of
one high-quality life year in patients
after radical prostatectomy amounted
59'526.9 rubles, after brachytherapy– 218'840.51 rubles. Received
data can be useful in working out the measures for optimization of options expenses, in development of national standards and protocols of prostate cancer treatment, in estimation of treatment charge rates due to compulsory health insurance and high-technology healthcare quotas.
|Download current article||412.66 KB|